PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate

BACKGROUND: Abiraterone acetate (AA) is widely used in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC). However, a significant percentage of patients will still progress, highlighting the need to identify patients more likely to benefit from AA. Parameters link...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: España, Sofia, Ochoa de Olza, Maria, Sala, Nuria, Piulats, Josep Maria, Ferrandiz, Ulises, Etxaniz, Olatz, Heras, Lucia, Buisan, Oscar, Pardo, Juan Carlos, Suarez, Jose F, Barretina, Pilar, Comet, Josep, Garcia del Muro, Xavier, Sumoy, Lauro, Font, Albert
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7584507/
https://ncbi.nlm.nih.gov/pubmed/33116879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S270392
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados